Centrality of the BS in Bioengineering Degree to the Clemson Univ. Mission
MISSION:
The mission of Clemson University is to fulfill the covenant between its founder and the people of South Carolina to establish a "high seminary of learning" through its historical land-grant responsibilities of teaching, research and extended public service. Clemson University is committed to fostering the economic development of South Carolina through training and research that will provide leadership to the state. Clearly, the proposed program meets the mission of the University and will provide a substantial tool to better serve the interests of the state.
The mission of Clemson University is to fulfill the covenant between its founder and the people of South Carolina to establish a "high seminary of learning" through its historical land-grant responsibilities of teaching, research and extended public service. Clemson University is committed to fostering the economic development of South Carolina through training and research that will provide leadership to the state. Clearly, the proposed program meets the mission of the University and will provide a substantial tool to better serve the interests of the state.
Over the past five years, with the expansion of its current bioengineering graduate program in mind, the administration of Clemson University has made strategic decisions to assure the successful implementation of this proposed undergraduate bioengineering program. The number of full-time faculty members in bioengineering has more than doubled, and new research laboratories in the Rhodes Research Center have been provided for them. Videoconferencing facilities were designed to stimulate collaboration with other institutions in- and out-of-state. Strategic partnerships with the Medical University of South Carolina and the Greenville Hospital University Medical Center were established. In 2003, Clemson University and the Medical University of South Carolina joined efforts to extend the bioengineering program into a clinical setting known as the CU-MUSC Bioengineering Program for both faculty and students. Currently, three faculty members and fifteen graduate students of the Department of Bioengineering are conducting research and academic activities at the Medical University of South Carolina in Charleston. This collaborative effort provides the necessary link between bioengineers and medical and surgical practice to conduct state-of-the-art bioengineering education and research. Both MD/PhD and DMD/PhD programs are jointly offered between Clemson and MUSC.
Through the support of the State of South Carolina’s Infrastructure Act and the Greenville Hospital System University Medical Center, Clemson University established the Innovative Biomedicine and Bioengineering Research and Training Program. Housed on the campus of the Greenville Hospital System University Medical Center (GHS-UMC) in Greenville, SC, this program furthers the development of clinically relevant technology for improving patient care and disease diagnosis, conducted by Clemson faculty and students. This strategic expansion will clearly position Clemson University and the State of South Carolina as national leaders in translational medical research, including multi-investigator research laboratories supplemented by clinical and industrial participation. Research conducted through this initiative will result in a large number of innovations in the practice of medicine and enhancement of patient-oriented outcomes while stimulating economic growth in the state through entrepreneurship. Targeted research areas include cardiovascular science and engineering, orthopaedic performance and biomechanics, regenerative medicine, tissue engineering, advanced surgical technologies, and drug development.
Both the CU-MUSC Bioengineering Program and the partnership with GHS will be fully integrated in the training of the undergraduate bioengineering students at the junior and senior level through summer or academic clinical and research internships, providing a unique education platform for bioengineers.
Through the support of the State of South Carolina’s Infrastructure Act and the Greenville Hospital System University Medical Center, Clemson University established the Innovative Biomedicine and Bioengineering Research and Training Program. Housed on the campus of the Greenville Hospital System University Medical Center (GHS-UMC) in Greenville, SC, this program furthers the development of clinically relevant technology for improving patient care and disease diagnosis, conducted by Clemson faculty and students. This strategic expansion will clearly position Clemson University and the State of South Carolina as national leaders in translational medical research, including multi-investigator research laboratories supplemented by clinical and industrial participation. Research conducted through this initiative will result in a large number of innovations in the practice of medicine and enhancement of patient-oriented outcomes while stimulating economic growth in the state through entrepreneurship. Targeted research areas include cardiovascular science and engineering, orthopaedic performance and biomechanics, regenerative medicine, tissue engineering, advanced surgical technologies, and drug development.
Both the CU-MUSC Bioengineering Program and the partnership with GHS will be fully integrated in the training of the undergraduate bioengineering students at the junior and senior level through summer or academic clinical and research internships, providing a unique education platform for bioengineers.
